Results 201 to 210 of about 940,273 (317)

Reconsidering the Toxoplasma gondii interactome: opportunities beyond crosslinking mass spectrometry

mBio
Nathkapach K. Rattanapitoon, Patpicha Arunsan, Nav La, Schawanya K. Rattanapitoon   +3 more
doaj   +1 more source

sEMG-Based Motion Intention Recognition for Interactive Upper Limb Nursing Assistance. [PDF]

Sensors (Basel)
Peng Z, Feng Y, Wu L, Cheng J, Fang X.
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Manufacturer and User Facility Device Experience (MAUDE)-Dash: An open-source, interactive dashboard for real-time post-market surveillance of medical devices. [PDF]

Surg Neurol Int
Porwal MH.
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

MolViewStories: Interactive molecular storytelling. [PDF]

Protein Sci
Slanináková T, Charlop-Powers Z, Doshchenko V, Rose AS, Midlik A, Sekuła A, Fonseca N, Morris KL, Burley SK, Velankar S, Fleming J, Vallat B, Autin L, Sehnal D.   +13 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Constellation Plots in KNIME: An Automated Scaffold-Based Workflow for Interactive Chemical Space Visualization. [PDF]

Mol Inform
Ramírez-Márquez CD, López-López E, Medina-Franco JL.   +2 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

ExposoGraph: An Interactive Platform for Carcinogen Bioactivation and Detoxification Pathway Visualization. [PDF]

Med Oncol
Kazi JU, Pienta KJ.
europepmc   +1 more source